Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Markets in Motion
April 2024
The big things you need to know: First, investor sentiment has taken a bit of a hit, but it’s too early to say the...
The big things you need to know: First, geopolitical concerns are spiking at a time when stocks already seemed due for...
Two big things you need to know: First, the Energy sector still looks attractive to us, even after its big move in...
Pathfinders in Biopharma
Q1 2024 saw a handful of IPOs in the biotech sector, and mounting excitement over novel treatments. But there are less...
The first quarter of 2024 has seen biotech’s funding drought broken, largely through private investment in public...
Three big things you need to know today: First, we lift our YE 2024 S&P 500 price target to 5,300 (from 5,150). The...
March 2024
Two big things you need to know today: First, our work on the R2000 relative to the S&P 600 (sparked by Small Cap PM...
Three big things you need to know: First, Energy has been a top S&P 500 sector since January. We like its attractive...
Three big things you need to know: First, one of our key sentiment indicators has started to retreat after hitting...
Get the latest insights from RBC Capital Markets delivered to your inbox.